Under pressure: paediatric hypertensive dilated cardiomyopathy secondary to renal artery stenosis

Emanuel Abosh1,2, Hiroko Asakai1,2, Philip Roberts1

  • 1Heart Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Cardiology in the Young
|October 8, 2025
PubMed

Insights

Severe pediatric dilated cardiomyopathy can stem from rare abnormal loading conditions like mid-aortic syndrome and renal artery stenosis. Prompt identification of hypertension and ventricular changes may reveal reversible causes.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Pathology
  • Nephrology

Background:

  • Dilated cardiomyopathy in children is typically idiopathic or genetic.
  • Abnormal loading conditions are an uncommon but critical differential diagnosis.
  • Mid-aortic syndrome and renal artery stenosis can lead to severe cardiac dysfunction.

Purpose of the Study:

  • To highlight a rare pediatric case of dilated cardiomyopathy.
  • To emphasize the association between mid-aortic syndrome, renal artery stenosis, and cardiac pathology.
  • To underscore the importance of recognizing reversible causes of pediatric heart failure.

Main Methods:

  • Case report presentation.
  • Review of clinical findings including refractory hypertension and echocardiographic evidence of left ventricular dilatation and hypertrophy.
  • Diagnostic workup for secondary causes of cardiomyopathy.

Main Results:

  • The patient presented with severe dilated cardiomyopathy.
  • The underlying cause was identified as mid-aortic syndrome with associated renal artery stenosis.
  • The cardiac condition was secondary to abnormal loading conditions.

Conclusions:

  • Mid-aortic syndrome with renal artery stenosis is a rare but significant cause of pediatric dilated cardiomyopathy.
  • Refractory hypertension and specific left ventricular changes are key indicators of potentially reversible causes.
  • Early diagnosis and management of these vascular abnormalities are crucial for improving cardiac outcomes in affected children.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
787
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
576
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
439
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
467